3.07Open3.07Pre Close0 Volume35 Open Interest10.00Strike Price0.00Turnover0.00%IV9.88%PremiumDec 20, 2024Expiry Date2.31Intrinsic Value100Multiplier5DDays to Expiry0.76Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.46Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Cryoport Stock Discussion
VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies
Cryoport, Inc. (NASDAQ: CYRX) and VGXI, Inc. have announced a strategic partnership to support biopharmaceutical companies in developing cell and gene therapies and mRNA-based treatments. The collaboration will commence in October 2024, with Cryoport Systems providing biostorage and bioservices from its Houston, Texas facility for plasmid DNA products manufact...
No comment yet